Eevia Health Plc (EEVIA.ST)
SEK 0.17
(4.29%)
SEK 0.17
(4.29%)
| Breakdown | 2023 | 2022 | 2020 | 2019 |
|---|---|---|---|---|
| Operating Cash Flow | 11.6 Million | -14.16 Million | 3.51 Million | -8.29 Million |
| Net Income | -10.16 Million | -21.72 Million | -10.73 Million | -4.3 Million |
| Depreciation & Amortization | 9.32 Million | 8.21 Million | 2.4 Million | 1.2 Million |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | 12.44 Million | -656.03 Thousand | 11.79 Million | -5.19 Million |
| Other non-cash items | 6.2 Million | 17.08 Million | -6.93 Million | 7.62 Million |
| Investing Cash Flow | -8.39 Million | -9.09 Million | -11.43 Million | -4.06 Million |
| Investments in PPE | -8.39 Million | -9.09 Million | -11.43 Million | -4.06 Million |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | -8.94 Million | 10.26 Million | 8.89 Million | 17.38 Million |
| Debt repayment | -2.1 Million | -4.58 Million | -8.89 Million | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 11.08 Million | 20.33 Million | - | 17.38 Million |
| Other Financing Activities | -17.92 Million | -14.64 Million | - | - |
| Accounts receivables | 1.55 Million | 5.51 Million | -4.14 Million | -1.31 Million |
| Accounts payables | -1.44 Million | -1.42 Million | 49.08 Million | -3.13 Million |
| Inventory | 12.33 Million | -4.74 Million | -33.14 Million | -751.79 Thousand |
| Other working capital | 1.08 Million | - | - | - |
| Cash at beginning of period | 7.09 Million | 19.14 Million | 6.13 Million | 109 Thousand |
| Cash at end of period | 1.53 Million | 7.09 Million | 6.81 Million | 6.13 Million |
| Capital Expenditure | -8.39 Million | -9.09 Million | -11.43 Million | -4.06 Million |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | -5.55 Million | -12.04 Million | 676.31 Thousand | 6.02 Million |
| Free Cash Flow | 3.2 Million | -23.25 Million | -7.92 Million | -12.35 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -558 Thousand | -4.36 Million | -10.16 Million | -4.45 Million | -3.72 Million | 4.73 Million |
| Depreciation & Amortization | 229 Thousand | 2.54 Million | 9.32 Million | 2.31 Million | 2.35 Million | 2.27 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 60 Thousand | -1.03 Million | 12.44 Million | 26.66 Million | -10.38 Million | -3.18 Million |
| Other non-cash items | - | 6.13 Million | 6.2 Million | -28.89 Million | 15.2 Million | 7.67 Million |
| Investing Cash Flow | -4000.00 | -1.09 Million | -8.39 Million | -3.54 Million | -2.8 Million | -752.33 Thousand |
| Investments in PPE | -4000.00 | -1.09 Million | -8.39 Million | -3.54 Million | -2.8 Million | -752.33 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -4000.00 | - | - | - | - | - |
| Financing Cash Flow | 261 Thousand | 3.11 Million | -8.94 Million | -18.2 Million | 16.43 Million | -398.85 Thousand |
| Debt repayment | -261 Thousand | -315.92 Thousand | -2.1 Million | -5.32 Million | -5.39 Million | -398.85 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 11.08 Million | 46.96 Thousand | 11.04 Million | - |
| Other Financing Activities | - | 3.43 Million | -17.92 Million | -17.92 Million | - | - |
| Accounts receivables | 53 Thousand | -1.86 Million | 1.55 Million | 2.98 Million | -5.09 Million | 4.14 Million |
| Accounts payables | - | 834.93 Thousand | -1.44 Million | 22.46 Million | -9.43 Million | -10 Million |
| Inventory | -128 Thousand | -11.28 Thousand | 12.33 Million | 1.21 Million | 4.13 Million | 2.68 Million |
| Other working capital | 135 Thousand | - | - | - | - | - |
| Cash at beginning of period | 63 Thousand | 1.53 Million | 7.09 Million | 5.69 Million | 3.75 Million | 912.54 Thousand |
| Cash at end of period | 51 Thousand | 727.52 Thousand | 1.53 Million | 1.53 Million | 5.69 Million | 3.75 Million |
| Capital Expenditure | -4000.00 | -1.09 Million | -8.39 Million | -3.54 Million | -2.8 Million | -752.33 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -12 Thousand | -811.66 Thousand | -5.55 Million | -4.15 Million | 1.93 Million | 2.84 Million |
| Free Cash Flow | -273 Thousand | -3.94 Million | 3.2 Million | 14.1 Million | -14.45 Million | 3.02 Million |
BIOM3
BMDPF
KLIB
7757
SOFT
BOZTY